Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT05152745 |
| Other study ID # |
519ginger |
| Secondary ID |
|
| Status |
Completed |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
May 5, 2017 |
| Est. completion date |
October 30, 2017 |
Study information
| Verified date |
November 2021 |
| Source |
Egas Moniz - Cooperativa de Ensino Superior, CRL |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
Background: Hyperglycemia is a risk factor to disease development, namely, diabetes mellitus.
The blood glucose level management, particularly on post-prandial period has an important
role in the prevention of different diseases. Ginger is a specie that has been demonstrated a
benefit effect on glycaemia on diabetes.
Aim: The aim of this study was 1) to investigate the effects of ginger infusion in the
glycaemic response in nondiabetic adults; 2) to evaluate total phenolic content the
antioxidant activity of Ginger (Zingiber officinale Roscoe) aqueous extracts.
Methodology: 24 nondiabetic subjects were randomly allocated into two groups: intervention
group (GI; n=15) and control group (GC; n=15). An oral glucose solution (OGTT) and an OGTT
following ginger extract solution were administrated in control and intervention groups,
respectively. Blood glucose levels were measurement at fasting and after 30, 60, 90 and 120
minutes after interventions in both groups. Total phenolic content and flavonoids compounds
determination of the aqueous ginger extract was determined according to Prabha method.
Antioxidant activity was also measured through ABTS method and free radicals inhibition
capacity. Repeated Measures ANOVA of mixed type and independent samples t-test were used in
statistical analysis.
Description:
This clinical trial was approved by Ethical Committee (process number 519 at 23 November
2016). All participants signed a written informed consent after aim and experimental risk
procedures explanation and its protected confidentiality was guaranteed. The experimental
procedure involving human was care out according Declaration of Helsinki.
This blind (to participants) randomized controlled clinical trial was conducted at Egas Moniz
higher education school in 30 nondiabetic adults. Participants with ages between 18 and 40
were selected and randomly allocated in intervention group (IG) (n=15) and control group (CG)
(n=15), in which participants were alternated include in the groups. The IG performed an oral
glucose tolerance test (OGTT) followed by aqueous ginger extract administration and the CG
performed an OGTT administration alone.
For ginger extract preparation, powder ginger (Zingibre officinalle Roscoe) was obtained from
Portugal Company with India origin and stored in a dried environmental locally until needed.
The product has a batch number of LI1GIGRNT150012. Powder ginger was individually weight
(0.2g each dose) and added to 100mL of boiled water obtaining the ginger extract, infusing 10
minutes. Ginger extract solution was after cooled at room temperature and distributed to each
participant. This method was adapted by Wilkinson, J. M. (2000). For chemical analysis, a
aqueous ginger extract previously obtained was used.
Regarding to blood glucose level assessment, the blood sample were collected for each
participant using a capillary drop blood before the intervention (fasting) and after 30, 60,
90 and 120 minutes. The blood glucose level analysis was performed using a strips for glucose
meter (Onetouch Select Plus Flex), a sterilized lancet and a glucose meter equipment.
General characteristics data of the participants were collected, namely, anthropometrics
data, pharmacologic treatment and medical condition using a questionnaire. In addition, a
24-hour dietary recall at the day before the intervention was employing to sample
participants. The nutritional analyzed of diet ingested was performed by Food Processor SQL
(version 10.5.0).
The total phenolic compounds determination of the aqueous ginger extract was determined
according to Folin-Ciocalteu method. The total phenolic results were expressed as mg gallic
acid equivalent (GAE)/L of ginger extract. A volume of 125 μL of ginger extract and 2 mL of
sodium carbonate were added to 2.5 mL of Folin-Ciocalteu reagent. After 15 min the absorbance
was measured at 765 nm. The flavonoids compounds determination of the aqueous ginger extract
was determined according to Prabha method. The flavonoids results were expressed as mg
quercetin equivalent (GAE)/L of ginger extract. A volume of 2 mL of ginger extract were added
to 0.1 mL of aluminum chloride anhydrous solution (10%), 0.1 mL of potassium acetate (1M) and
2.8 mL of distilled water. After 30 min the absorbance was measured at 415 nm.
The antioxidant activity was measured through different assays:
The superoxide anion radicals scavenging activity was determined based on Morais et al
method. Superoxide anion was generated by reacting phenazine methosulfate (PMS), nicotinamide
adenine dinucleotide hydride (NADH), and oxygen causing reduced NBT in Formazan. A volume of
0.5mL of sample was added to 0.5mL of a solution containing NADH (189 microM) and NBT (120
microM) with Tris-HCl (40mM, pH = 8). The reaction started after the addition of 0.5mL of PMS
(60microM). Control sample was measured using only distilled water. After 5min of incubation,
control absorbance was measured at 560 nm at room temperature.
The nitric oxide inhibitory activity was determined according Khayami et al method. A volume
of 1mL of sodium nitroprusside 10nm was added to 250microL de phosphate buffered saline (PBS)
and 250microL of test solution and it was shaken. The previous solution was incubated for 150
min at 25ºC and following add 3mL of sulfanilic acid and 0.33% of acetic acid glacial. After
5 min at room temperature, it was add 3mL of n-(1-naphthyl)ethylenediamine dihydrochloride
(NED, 0.1% m/v) and incubated for 30 min at 25ºC. The absorbance was measured at 533nm. The
previous procedure was employed to control obtained using water.
The free radical 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) was obtained
by ABTS oxidation with potassium persulfate 140mM for 12h in dark, according Zulueta et al
method. It was prepared a solution with 10mL ABTS 7nm and 176microL persulfate and storage at
room temperature by 12h in dark. The previous solution was diluted with ethanol until 0.7
absorbance at 734nm. A volume of 2850microL of ABTS radical was added to 150microL of sample
and to 150microL of water. After 30min in dark the absorbance was determined at 734nm. The
Trolox concentration was using as standard (mM Trolox/L). This test was performed for several
extract concentrations in order to calculate IC50.
Data statistical analysis was performed using SPSS Statistics (Statistical Package for Social
Sciences) (version 22) software. Mean and standard error of the mean were used. Shapiro-Wilk
and Repeated Measures ANOVA of mixed type were used. Independent samples T-test was used to
assess the difference between the 2 groups for total caloric value, carbohydrates, protein
and lipid ingested, Cmax (maximum concentration), ΔCmax (variation of maximum concentration),
and AUC (area under the curve) Incremental values. The AUC was calculated by Software
GraphPad Prim (version 7.03). All statistical tests were performed at the 5% level of
significance.
